Form 4 for RLMD RELMADA THERAPEUTICS, INC.
Accepted 2022-07-05 00:00:00 ET · period of report 2022-06-30 · accession 0001213900-22-037231 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-07-05 | 2022-06-30+ | RLMD | TRAVERSA SERGIO | CEO, Dir | M - OptEx | $16.00 | +29.8K | 104.8K | +40% | +$476.3K |
| DM | 2022-07-05 | 2022-06-30+ | RLMD | TRAVERSA SERGIO | CEO, Dir | S - Sale+OE | $18.80 | -29.8K | 101.7K | -23% | -$559.6K |
| DM | 2022-07-05 | 2022-06-30+ | RLMD | TRAVERSA SERGIO | CEO, Dir | M - OptEx | $0.00 | -29.8K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-07-01 | M | A | 13,755 | $16.00 | 102,529 | D | — | — | |
| 2 | Common | Common Stock | 2022-06-30 | S | D | 10,698 | $19.01 | 88,774 | D | — | — | (F2) The number of securities reported represents an aggregate number of shares sold in multiple open market transactions over a range of sales prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range. (F4) Sales prices range from $19.00 to $19.15 per share, inclusive. |
| 3 | Common | Common Stock | 2022-06-30 | S | D | 5,314 | $19.37 | 99,472 | D | — | — | (F2) The number of securities reported represents an aggregate number of shares sold in multiple open market transactions over a range of sales prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range. (F3) Sales prices range from $19.20 to $19.51 per share, inclusive. |
| 4 | Common | Common Stock | 2022-06-30 | M | A | 16,012 | $16.00 | 104,786 | D | — | — | |
| 5 | Common | Common Stock | 2022-07-01 | S | D | 4,068 | $18.32 | 88,774 | D | — | — | (F2) The number of securities reported represents an aggregate number of shares sold in multiple open market transactions over a range of sales prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range. (F7) Sales prices range from $18.26 to $18.44 per share, inclusive. |
| 6 | Common | Common Stock | 2022-07-01 | S | D | 8,848 | $18.45 | 92,842 | D | — | — | (F2) The number of securities reported represents an aggregate number of shares sold in multiple open market transactions over a range of sales prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range. (F6) Sales prices range from $18.45 to $18.47 per share, inclusive. |
| 7 | Common | Common Stock | 2022-07-01 | S | D | 839 | $18.48 | 101,690 | D | — | — | (F2) The number of securities reported represents an aggregate number of shares sold in multiple open market transactions over a range of sales prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range. (F5) Sales prices range from $18.47 to $18.53 per share, inclusive. |
| 8 | Derivative | Stock Option (right to buy) | 2022-06-30 | M | D | 16,012 | $0.00 | 13,755 | D | $16.00 · 2012-07-10 to 2022-07-10 | 16,012 Common Stock | (F8) The options were granted on July 10, 2012 (the "Grant Date"). 25% of the options vested upon the Grant Date and the remaining 75% of the options vested in equal quarterly increments over the next four (4) years, so that the last set of options vested in July 2016. |
| 9 | Derivative | Stock Option (right to buy) | 2022-07-01 | M | D | 13,755 | $0.00 | 0 | D | $16.00 · 2012-07-10 to 2022-07-10 | 13,755 Common Stock | (F8) The options were granted on July 10, 2012 (the "Grant Date"). 25% of the options vested upon the Grant Date and the remaining 75% of the options vested in equal quarterly increments over the next four (4) years, so that the last set of options vested in July 2016. |